Ginkgo Bioworks Holdings Total Assets 2020-2022 | DNA

Ginkgo Bioworks Holdings total assets from 2020 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ginkgo Bioworks Holdings Annual Total Assets
(Millions of US $)
2021 $2,071
2020 $675
2019 $0
Ginkgo Bioworks Holdings Quarterly Total Assets
(Millions of US $)
2022-03-31 $2,058
2021-12-31 $2,071
2021-09-30 $2,151
2021-06-30 $1,726
2021-03-31 $1,728
2020-12-31 $0
2020-09-30 $0
2019-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.957B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $170.283B 10.36
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.670B 16.84
Biohaven Pharmaceutical Holding (BHVN) United States $10.157B 0.00
Arcus Biosciences (RCUS) United States $1.815B 46.02
Emergent Biosolutions (EBS) United States $1.640B 7.02
Myovant Sciences (MYOV) United Kingdom $1.243B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.098B 0.00
Ambrx Biopharma (AMAM) United States $0.098B 0.00
SQZ Biotechnologies (SQZ) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00